FDA Peptide Reclassification 2026: What It Means for Providers BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with The FDA's Ban of Therapeutic Peptides: A Threat to Health Freedom Slim 'n Sleek BPC 157 Benefits, Dosage & Before After Results The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York